Courses by PeerVoice (23)
-
PeerVoice, Siyemi Europe Limited PeerVoice – Emerging CAR-T Strategies in gMG and SPS: What Are We Learning About Their Therapeutic Potential?
-
PeerVoice, Siyemi Europe Limited PeerVoice – Testing. Targeting. Transforming: Practical Guidance for the Management of HER2-Positive Gastrointestinal Cancers – Enduring
-
PeerVoice, Siyemi Europe Limited PeerVoice – Testing. Targeting. Transforming: Practical Guidance for the Management of HER2-Positive Gastrointestinal Cancers – Live
-
PeerVoice, Siyemi Europe Limited PeerVoice – What s Now and What s Next: The Evolving Treatment Landscape for Progressive MS
-
PeerVoice, Siyemi Europe Limited PeerVoice – Recognising Progression Beyond Relapse: Clinical Challenges and Emerging Approaches in Progressive MS
-
PeerVoice, Siyemi Europe Limited PeerVoice – Translating Evidence Into Individualized Decisions Across the Spectrum of SCLC: Expert Insights on Contemporary Cases
-
PeerVoice, Siyemi Europe Limited PeerVoice – Shifting the Status Quo in LS-SCLC: The Practicalities of Integrating Immunotherapy Into Treatment Pathways
-
PeerVoice, Siyemi Europe Limited PeerVoice – Hope is on the Horizon: Anticipating Novel Treatment Approaches in Advanced Pancreatic Cancer
-
PeerVoice, Siyemi Europe Limited PeerVoice – Navigating the Changing Landscape of mCRPC Management: Reviewing Roads Travelled and Exploring Emerging Directions – Enduring
-
PeerVoice, Siyemi Europe Limited PeerVoice – Navigating the Changing Landscape of mCRPC Management: Reviewing Roads Travelled and Exploring Emerging Directions – Live
-
PeerVoice, Siyemi Europe Limited PeerVoice – Re-Evaluating the Role of Radiopharmaceuticals in the Management of mCRPC: How Should Recent Data Inform Individualized Treatment? – Enduring
-
PeerVoice, Siyemi Europe Limited PeerVoice – When Less is More: Taking a Closer Look at Next-Generation Gadolinium-Based Contrast Agents in Contrast-Enhanced MRI
-
PeerVoice, Siyemi Europe Limited PeerVoice – C3G and IC-MPGN Clinically Considered: A Real World Case Based Masterclass in Complement Inhibition
-
PeerVoice, Siyemi Europe Limited PeerVoice – A Case-Based Masterclass Series: Guidelines to Practice in The Management of IgAN
-
PeerVoice, Siyemi Europe Limited PeerVoice – Strategies To Success in IgAN Management: Harmonizing The Latest Evidence & Guidance To Maximize The Potential of Foundation Treatment Strategies
-
PeerVoice, Siyemi Europe Limited PeerVoice – Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Mind – Enduring
-
PeerVoice, Siyemi Europe Limited PeerVoice – Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast Cancer
-
PeerVoice, Siyemi Europe Limited PeerVoice – Beyond the Virus: New Strategies to Improve Outcomes of Non-HPV Associated Recurrent/Metastatic Head and Neck Cancer – Enduring
-
PeerVoice, Siyemi Europe Limited PeerVoice – Deepening the Dialogue on the Latest Data for Factor XIa Inhibition: Is It Time to Shift the Paradigm in Secondary Stroke Prevention? Enduring
-
PeerVoice, Siyemi Europe Limited PeerVoice-Turning Pathophysiologic Promise Into Evidence-Based Potential: Is Factor XIa Inhibition Ready for Prime Time in Secondary Stroke Prevention – Enduring
-
PeerVoice, Siyemi Europe Limited PeerVoice – The Emerging Nuances of Extensive Stage SCLC Treatment: Individualizing Care in the Immunotherapy Era
-
PeerVoice, Siyemi Europe Limited PeerVoice – 2025 Congress Highlights from Houston, Texas: Translating C3G and IC-MPGN Trials To Treatment in an Era of Complement Inhibition
-
PeerVoice, Siyemi Europe Limited PeerVoice – 2025 Congress Highlights From Houston, Texas: A Fresh Look At The Data Driving Targeted Therapeutic Developments In IgA Nephropathy
